Corcept Therapeutics (CORT) PT Raised to $150 at Canaccord
Canaccord analyst Edward Nash raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)